Progress's latest activity

  • P
    Progress replied to the thread Semaglutide: What to know?.
    The pricing gap between branded and generic versions coming to market is one of the more consequential access variables - US patients...
  • P
    Progress replied to the thread Humanofort - Anyone know?.
    Humanofort isn't commonly tested because the active components aren't well characterized - the regulatory pathway is unclear and most...
  • P
    Progress replied to the thread GLP-1 non-responders?.
    Response variability is mostly receptor density - super-responders tend to have higher baseline GIP/GLP-1 receptor expression.
Back
Top